Cerus Corporation
CERSNASDAQHealthcare● Active
$2.60
$-0.11(-4.06%)
Market Cap$520959332
P/E Ratio—
52W High$3.15
52W Low$1.15
Cerus Corporation (CERS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CERS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.21B | $0.18B | $0.16B | $0.16B | $0.13B |
| Cost of Revenue | $0.10B | $0.08B | $0.07B | $0.07B | $0.06B |
| Gross Profit | $0.11B | $0.10B | $0.09B | $0.09B | $0.07B |
| Gross Margin %(computed) | 53.50% | 55.21% | 55.25% | 53.75% | 51.49% |
| Operating Expenses | |||||
| R&D Expenses | $0.07B | $0.06B | $0.07B | $0.06B | $0.06B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.15B | $0.11B | $0.12B | $0.12B | $0.12B |
| Operating Income | ($0.04B) | ($0.01B) | ($0.03B) | ($0.03B) | ($0.05B) |
| Operating Margin %(computed) | -17.63% | -7.89% | -19.22% | -21.03% | -37.40% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.02B) | ($0.04B) | ($0.04B) | ($0.05B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.02B) | ($0.02B) | ($0.04B) | ($0.04B) | ($0.05B) |
| Net Margin %(computed) | -7.58% | -11.60% | -23.98% | -26.40% | -41.55% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.08 | $-0.11 | $-0.21 | $-0.24 | $-0.32 |
| Wtd Avg Shares | 0.19B | 0.18B | 0.18B | 0.18B | 0.17B |
| EBITDA | ($0.03B) | ($0.01B) | ($0.03B) | ($0.03B) | ($0.05B) |
| EBITDA Margin %(computed) | -16.66% | -5.56% | -16.84% | -20.69% | -35.14% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Cerus Corporation data
About Cerus Corporation (CERS) Income Statement
Cerus Corporation (CERS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CERS reported revenue of $0.21B, gross profit of $0.11B (gross margin 53.50%), and net income of ($0.02B) — a net profit margin of -7.58%.
Frequently asked questions
CERS · 4 questionsCerus Corporation (CERS) reported revenue of $0.21B for 2025, up 14.3% year-over-year.
CERS revenueCERS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08